From WisPolitics.com/WisBusiness.com …
— Inner Haven Wellness is expanding into the Milwaukee area, the eating disorder treatment provider announced today.
Starting Jan. 5, the care provider will begin offering adult partial hospitalization and intensive outpatient programs at a facility in Brookfield. That’s in addition to its existing sites in Madison and Neenah.
The company’s treatment model includes nutrition and behavioral therapy, medical monitoring and other offerings for adults with anorexia, bulimia, binge eating disorder and other conditions.
Dr. Margherita Mascolo, CEO and chief medical officer for Inner Haven Wellness, says its approach aims to make clients feel “deeply understood and medically supported” as they seek treatment for eating disorders.
“With this expansion, Inner Haven will serve the most populated region of Wisconsin with specialized eating disorder care, reaching adults, families, and providers who have been waiting too long for local options,” she said in a statement.
See the release below.
— The latest round of SBIR Advance grantees in Wisconsin includes two small businesses developing health care innovations.
The state’s Center for Technology Commercialization today announced five companies receiving matching grants as they work on projects in the federal Small Business Innovation Research or Small Business Technology Transfer programs.
One Phase 1 recipient, Madison-based Tensense, aims to improve total knee replacement procedures through better tissue assessment during surgery, according to the announcement. As with the other three Phase 1 grantees, the company is getting a $75,000 matching grant.
Meanwhile, Milwaukee’s ReNeuroGen is getting a $100,000 match as a Phase 2 recipient. The pharmaceutical company is developing a drug to treat various inflammatory conditions.
See more in the release below.
Top Stories
– Feds Promised ‘Radical Transparency’ but Are Withholding Rural Health Fund Applications
– Vaccine Committee May Make Significant Changes to Childhood Schedule
– Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change
– The FDA’s top drug regulator submits his resignation to the agency
– US Supreme Court poised to side with anti-abortion pregnancy centers in New Jersey case
– Solving the Home Care Quandary
Press Releases
